Netalytics, LLC

Based in South Carolina, US, and founded in 1955 by CEO Mark Essex, Netalytics, LLC offers EHR and practice management solutions tailored for Opioid Use Disorder ("OUD") providers in the substance use disorder market, providing a comprehensive suite of purpose-built tools that cover inventory management, dosing control, and regulatory compliance tracking. In October 2023, Netsmart Technologies, Inc. , a portfolio company of GI Partners and TA Associates, acquired Netalytics from Prairie Capital.   The cornerstone of Netalytics' product offering is the Methasoft Treatment Management System, which is designed specifically for opiate addiction treatment facilities.

This comprehensive software automates various clinic processes, making it a world leader in the automatic dispensing of methadone. In addition, Netalytics offers an array of supplementary products and services to enhance the treatment and management of patients, including e-prescribing, counselling services, support, monitoring, and treatment of DUI and DWI offenders. In addition, the company’s product range includes a mobile application for streamlined check-in and payments, a patient check-in process streamlining add-on, and a large-screen display showcasing real-time dosing queues in clinic waiting areas. Analytics also offers essential supplies, such as SciLog LabTec Methadone Dispensers and IVEK MethaSpense Pumps, crucial to their treatment automation solutions.